We are live on
!
Find out more
SP
Symmetry Partners Portfolio holdings
AUM
$1.96B
1-Year Est. Return
19.83%
This Fund
S&P 500
This Quarter
Est. Return
-3.27%
1 Year Est. Return
+19.83%
3 Year Est. Return
+58.53%
5 Year Est. Return
+62.51%
10 Year Est. Return
–
AUM
$1.59B
AUM Growth
+$18.4M
(+1.2%)
Cap. Flow
+$84.8M
Cap. Flow
% of AUM
5.33%
Top 10 Holdings %
Top 10 Hldgs %
33.4%
Holding
616
New
13
Increased
89
Reduced
73
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders US Aggregate Bond ETF
BBAG
|
+$63.1M |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$11.6M |
| 3 |
Vanguard Morningstar Value ETF
VTV
|
+$7.38M |
| 4 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$6.74M |
| 5 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$6.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap Value ETF
VOE
|
+$21.3M |
| 2 |
abrdn Physical Precious Metals Basket Shares ETF
GLTR
|
+$12.8M |
| 3 |
iShares MSCI Intl Momentum Factor ETF
IMTM
|
+$11.4M |
| 4 |
FM
iShares Frontier and Select EM ETF
FM
|
+$4.04M |
| 5 |
Pfizer
PFE
|
+$3.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.36% |
| 2 | Financials | 5.72% |
| 3 | Healthcare | 4.65% |
| 4 | Industrials | 4.08% |
| 5 | Consumer Discretionary | 3.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Cencora
COR
$61.2B
| $640K | 0.04% |
4,139
| – | – |
|
302
PPG Industries
PPG
$26.6B
| $639K | 0.04% |
4,876
| – | – |
|
303
Ubiquiti
UI
$34.3B
| $636K | 0.04% |
2,185
-203
| -9% | -$54.9K |
|
304
SLM Corp
SLM
$5.15B
| $635K | 0.04% |
34,592
| – | – |
|
305
Corteva
CTVA
$51.3B
| $634K | 0.04% |
11,028
| – | – |
|
306
Zions Bancorporation
ZION
$10.3B
| $633K | 0.04% |
9,657
| – | – |
|
307
Bio-Rad Laboratories Class A
BIO
$9.42B
| $628K | 0.04% |
1,115
| – | – |
|
308
Packaging Corp of America
PKG
$22.8B
| $622K | 0.04% |
3,983
| – | – |
|
309
Southern Company
SO
$107B
| $621K | 0.04% |
8,571
| – | – |
|
310
FedEx
FDX
$75.4B
| $612K | 0.04% |
2,647
+1,232
| +87% | +$289K |
|
|
SGI
311
Somnigroup International
SGI
$13.7B
| $611K | 0.04% |
21,888
| – | – |
|
312
NVR
NVR
$17B
| $608K | 0.04% |
136
| – | – |
|
313
Labcorp
LH
$25.9B
| $600K | 0.04% |
2,648
-483
| -15% | -$114K |
|
314
Fidelity National Financial
FNF
$13.5B
| $596K | 0.04% |
12,690
| – | – |
|
315
Centene
CNC
$32.5B
| $593K | 0.04% |
7,039
| – | – |
|
316
Marvell Technology
MRVL
$196B
| $593K | 0.04% |
8,264
| – | – |
|
317
Ulta Beauty
ULTA
$24.3B
| $593K | 0.04% |
1,490
| – | – |
|
318
Ametek
AME
$58.2B
| $592K | 0.04% |
4,447
| – | – |
|
319
Aflac
AFL
$62.6B
| $591K | 0.04% |
9,183
| – | – |
|
320
Becton Dickinson
BDX
$48.2B
| $589K | 0.04% |
2,271
| – | – |
|
321
Kinder Morgan
KMI
$68.7B
| $588K | 0.04% |
31,095
| – | – |
|
322
Moody's
MCO
$82.7B
| $588K | 0.04% |
1,743
| – | – |
|
323
Robert Half
RHI
$4.37B
| $586K | 0.04% |
5,129
| – | – |
|
324
Colgate-Palmolive
CL
$74.4B
| $584K | 0.04% |
7,701
| – | – |
|
|
ANSS
325
DELISTED
Ansys
ANSS
| $578K | 0.04% |
1,821
| – | – |
|
Similar funds
HA
NIM
TCM
FC
BC
FFH
RMCM
OCM
Symmetry Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Symmetry Partners held 616 positions worth $1.59B, up 1.2% from $1.57B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Symmetry Partners deployed $84.8M of net new capital in Q1 2022, opening 13 new positions and adding to 89 existing holdings. Its largest new stake was JPMorgan BetaBuilders US Aggregate Bond ETF: 1,213,000 shares worth $61.3M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 9.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $3.51M trimmed.
- Symmetry Partners's largest Q1 2022 buy was JPMorgan BetaBuilders US Aggregate Bond ETF: 1,213,000 shares worth $61.3M.
- Symmetry Partners added most to Vanguard Short-Term Bond ETF in Q1 2022, an estimated $11.6M increase.
- Symmetry Partners's biggest Q1 2022 reduction was Pfizer, cutting an estimated $3.51M.
- Symmetry Partners fully exited Vanguard Morningstar Mid-Cap Value ETF in Q1 2022, selling an estimated $21.3M.
- Symmetry Partners's ten largest holdings make up 33% of its $1.59B portfolio in Q1 2022.
- Symmetry Partners opened 13 new positions and closed 45 in Q1 2022.
- Symmetry Partners's portfolio value rose 1.2% quarter-over-quarter to $1.59B.
Based on Symmetry Partners's 13F filing for Q1 2022, filed 4 Apr 2022.